|
⚲
|
| Keyboard |
| Behzad Aghazadeh | |
|---|---|
| Firm | |
| Address | 110 Greene Street Suite 800 New York, NY 10012 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Avoro Ventures Fund II LP | 021-591204 | Executive Officer | |||
| AADI Bioscience Inc | 021-541194 | Director | 100.0 M of 100.0 M |
||
| AADI Bioscience Inc | 021-461325 | Director | 72.5 M of 72.5 M |
||
| Scribe Therapeutics Inc | 021-394477 | Director | 100.0 M of 100.0 M |
||
| Avoro Life Sciences Fund LLC | 021-146405 | Executive Officer | 3,333.1 M | ||
| Avoro Capital Advisors LLC | |||||
| Avoro Ventures Fund LP | 021-388922 | Executive Officer | 178.4 M | 153.5 M | |
| Avoro Life Sciences Fund LLC | 021-146407 | Executive Officer | 2,110.0 M | 13.40 B | |